Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Heparin bridge is associated with more post-polypectomy bleeding and emergency department visits among anticoagulated patients.

Rebello D, Bakhit M, McCarty TR, Machan JT, Nagar A, Moss SF.

Ann Gastroenterol. 2020 Jan-Feb;33(1):73-79. doi: 10.20524/aog.2019.0430. Epub 2019 Nov 1.

2.

Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity.

Shirin H, Richter V, Matalon S, Abramowich D, Maliar A, Shachar E, Moss SF, Broide E.

Obes Sci Pract. 2019 Jun 25;5(4):376-382. doi: 10.1002/osp4.343. eCollection 2019 Aug.

3.

Treatment of Helicobacter pylori.

Argueta EA, Moss SF.

Curr Opin Gastroenterol. 2019 Nov;35(6):544-550. doi: 10.1097/MOG.0000000000000578.

PMID:
31433314
4.

Helicobacter pylori Infection.

Fallone CA, Moss SF, Malfertheiner P.

N Engl J Med. 2019 Aug 8;381(6):588. doi: 10.1056/NEJMc1905439. No abstract available.

PMID:
31390512
5.

Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment.

Argueta EA, Moss SF.

Aliment Pharmacol Ther. 2019 Aug;50(3):331-332. doi: 10.1111/apt.15302. No abstract available.

PMID:
31313363
6.

The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System: a multicenter clinical study in 257 subjects.

Richter V, Gonzalez JO, Hazan S, Gottlieb G, Friedenberg K, Gatof D, Ganeshappa R, Delgado JS, Abramowitz D, Hardi R, Coates A, Haq M, Mehta N, Jones BA, Moss SF, Shirin H.

Ther Adv Gastrointest Endosc. 2019 May 30;12:2631774519843401. doi: 10.1177/2631774519843401. eCollection 2019 Jan-Dec.

7.

Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA.

Alsamman MA, Vecchio EC, Shawwa K, Acosta-Gonzales G, Resnick MB, Moss SF.

Dig Dis Sci. 2019 Oct;64(10):2893-2898. doi: 10.1007/s10620-019-05694-4. Epub 2019 Jun 11.

PMID:
31187323
8.

Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.

Fallone CA, Moss SF, Malfertheiner P.

Gastroenterology. 2019 Jul;157(1):44-53. doi: 10.1053/j.gastro.2019.04.011. Epub 2019 Apr 15. Review.

PMID:
30998990
9.

Analysis of Accredited Gastroenterology Fellowship Internet-Available Content: Twenty-Nine Steps Toward a Better Program Website.

Ruddell JH, Eltorai AEM, Bakhit M, Lateef AM, Moss SF.

Dig Dis Sci. 2019 May;64(5):1074-1078. doi: 10.1007/s10620-019-05579-6.

PMID:
30863954
10.

Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review.

Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1261-1269. doi: 10.1097/MEG.0000000000001210.

PMID:
30044236
11.

Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2018 Jul;113(7):1102. doi: 10.1038/s41395-018-0132-6.

PMID:
29895984
12.

Editorial: Helicobacter pylori resistance and sequential therapy.

Siddique O, Moss SF.

Aliment Pharmacol Ther. 2018 Jul;48(1):95-96. doi: 10.1111/apt.14643. No abstract available.

13.

Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018.

Pellicano R, Zagari RM, Zhang S, Saracco GM, Moss SF.

Minerva Gastroenterol Dietol. 2018 Sep;64(3):310-321. doi: 10.23736/S1121-421X.18.02492-3. Epub 2018 Mar 30. Review.

14.

Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6. doi: 10.1016/j.cgh.2018.03.013. Epub 2018 Mar 17. Erratum in: Clin Gastroenterol Hepatol. 2019 Mar;17(4):801. Crowe, Sheila [corrected to Crowe, Sheila E].

15.

Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance.

Siddique O, Ovalle A, Siddique AS, Moss SF.

Am J Med. 2018 May;131(5):473-479. doi: 10.1016/j.amjmed.2017.12.024. Epub 2018 Jan 17. Review.

PMID:
29353050
16.

Response to Hsu et al.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2018 Jan;113(1):143. doi: 10.1038/ajg.2017.401. No abstract available.

PMID:
29311737
17.

Lymphoid follicles in children with Helicobacter pylori-negative gastritis.

Broide E, Richter V, Mendlovic S, Shalem T, Eindor-Abarbanel A, Moss SF, Shirin H.

Clin Exp Gastroenterol. 2017 Aug 11;10:195-201. doi: 10.2147/CEG.S133421. eCollection 2017.

18.

Celiac Disease and Increased Risk of Pneumococcal Infection: A Systematic Review and Meta-Analysis.

Simons M, Scott-Sheldon LAJ, Risech-Neyman Y, Moss SF, Ludvigsson JF, Green PHR.

Am J Med. 2018 Jan;131(1):83-89. doi: 10.1016/j.amjmed.2017.07.021. Epub 2017 Aug 8. Review.

PMID:
28801224
19.

H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.

Alzahrani S, Nelson J, Moss SF, Paulus JK, Knowler WC, Pittas AG; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2017 Oct;31(10):1515-1520. doi: 10.1016/j.jdiacomp.2017.05.015. Epub 2017 Jun 3.

20.

Response to Georgopoulos et al.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2017 Jul;112(7):1169-1170. doi: 10.1038/ajg.2017.127. No abstract available.

PMID:
28725080
21.

The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer.

Moss SF.

Cell Mol Gastroenterol Hepatol. 2016 Dec 27;3(2):183-191. doi: 10.1016/j.jcmgh.2016.12.001. eCollection 2017 Mar. Review.

22.

Cell recruitment in gastric carcinogenesis.

Zhang S, Moss SF.

Aging (Albany NY). 2017 Jan 25;9(1):1-2. doi: 10.18632/aging.101164. No abstract available.

23.

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10. Erratum in: Am J Gastroenterol. 2018 Jul;113(7):1102.

PMID:
28071659
24.

Fatal Streptococcus pneumoniae Sepsis in a Patient With Celiac Disease-Associated Hyposplenism.

Ouseph MM, Simons M, Treaba DO, Yakirevich E, Green PH, Bhagat G, Moss SF, Mangray S.

ACG Case Rep J. 2016 Oct 12;3(4):e140. eCollection 2016 Aug.

25.

Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice.

Zhang S, Kim W, Pham TT, Rogers AB, Houghton JM, Moss SF.

Oncotarget. 2016 Oct 25;7(43):69136-69148. doi: 10.18632/oncotarget.12049.

26.

Ulcerative Colitis Presenting With Palmoplantar Neutrophilic Dermatosis.

Levin SR, Ziud H, Jimoh OY, Tseng YA, Robinson-Bostom L, Moss SF.

Am J Gastroenterol. 2016 Jul;111(7):923. doi: 10.1038/ajg.2016.74. No abstract available.

PMID:
27356815
27.

Consensus on biomarkers for neuroendocrine tumour disease.

Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J.

Lancet Oncol. 2015 Sep;16(9):e435-e446. doi: 10.1016/S1470-2045(15)00186-2. Review.

28.

A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal.

Lee RT, Ferreira J, Friedman K, Moss SF.

Int J Colorectal Dis. 2015 Sep;30(9):1291-2. doi: 10.1007/s00384-015-2317-4. Epub 2015 Jul 23. No abstract available.

PMID:
26198995
29.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2015 Apr 10;359(2):345-51. Erratum in: Cancer Lett. 2015 Apr 10;359(2):344.

PMID:
25853150
30.

Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.

Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D.

Crit Rev Oncog. 2014;19(6):469-81. Review.

31.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2014 Dec 1;355(1):106-12. doi: 10.1016/j.canlet.2014.09.010. Epub 2014 Sep 11.

32.

Obesity and related risk factors in gastric cardia adenocarcinoma.

Olefson S, Moss SF.

Gastric Cancer. 2015 Jan;18(1):23-32. doi: 10.1007/s10120-014-0425-4. Epub 2014 Sep 11. Review.

PMID:
25209115
33.

Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.

Ferreira J, Moss SF.

Curr Treat Options Gastroenterol. 2014 Dec;12(4):373-84. doi: 10.1007/s11938-014-0027-6.

PMID:
25187235
34.

At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Dalal RS, Moss SF.

J Leukoc Biol. 2014 Aug;96(2):213-24. doi: 10.1189/jlb.4BT0214-100R. Epub 2014 May 13. Review.

35.

Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods.

Zhang S, Desrosiers J, Aponte-Pieras JR, DaSilva K, Fast LD, Terry F, Martin WD, De Groot AS, Moise L, Moss SF.

PLoS One. 2014 Apr 16;9(4):e94974. doi: 10.1371/journal.pone.0094974. eCollection 2014.

36.

How can we rationally select Helicobacter pylori therapy without resistance data?

Moss SF.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1578. doi: 10.1016/j.cgh.2014.02.029. Epub 2014 Feb 25. No abstract available.

PMID:
24582566
37.
38.

Inflammation, immunity, vaccines for Helicobacter pylori infection.

Koch M, Meyer TF, Moss SF.

Helicobacter. 2013 Sep;18 Suppl 1:18-23. doi: 10.1111/hel.12073. Review.

PMID:
24011240
39.

Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination.

Tang X, Wen S, Zheng D, Tucker L, Cao L, Pantazatos D, Moss SF, Ramratnam B.

PLoS One. 2013 Aug 29;8(8):e72503. doi: 10.1371/journal.pone.0072503. eCollection 2013.

40.

Gastroenterology Clinics of North America. Gastric cancer. Preface.

Moss SF.

Gastroenterol Clin North Am. 2013 Jun;42(2):xiii-xiv. doi: 10.1016/j.gtc.2013.02.002. Epub 2013 Feb 13. No abstract available.

PMID:
23639649
41.

Expression of bile acid receptor TGR5 in gastric adenocarcinoma.

Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF, Resnick MB.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G322-7. doi: 10.1152/ajpgi.00263.2012. Epub 2012 Dec 13.

42.

Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics.

Moise L, Moss SF, De Groot AS.

Expert Rev Vaccines. 2012 Sep;11(9):1031-3. doi: 10.1586/erv.12.80. No abstract available.

PMID:
23151160
43.

Rodent models of Helicobacter infection, inflammation, and disease.

Zhang S, Moss SF.

Methods Mol Biol. 2012;921:89-98. Review.

44.

Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter.

Byun SW, Chang YJ, Chung IS, Moss SF, Kim SS.

Cancer Lett. 2012 Dec 29;326(1):96-104. doi: 10.1016/j.canlet.2012.07.032. Epub 2012 Aug 4.

45.

Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infection.

Ruiz VE, Sachdev M, Zhang S, Wen S, Moss SF.

J Immunol Methods. 2012 Oct 31;384(1-2):157-63. doi: 10.1016/j.jim.2012.07.002. Epub 2012 Jul 16.

46.

Regulation of RKIP function by Helicobacter pylori in gastric cancer.

Moen EL, Wen S, Anwar T, Cross-Knorr S, Brilliant K, Birnbaum F, Rahaman S, Sedivy JM, Moss SF, Chatterjee D.

PLoS One. 2012;7(5):e37819. doi: 10.1371/journal.pone.0037819. Epub 2012 May 25.

47.

Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen.

Watson JB, Moss SF.

Am J Gastroenterol. 2011 Nov;106(11):1976-7. doi: 10.1038/ajg.2011.309.

PMID:
22056576
48.

H. pylori vaccines: why we still don't have any.

Zhang S, Moise L, Moss SF.

Hum Vaccin. 2011 Nov;7(11):1153-7. doi: 10.4161/hv.7.11.17655. Epub 2011 Nov 1.

49.

Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.

Wen S, So Y, Singh K, Slingerland JM, Resnick MB, Zhang S, Ruiz V, Moss SF.

Oncogene. 2012 Apr 5;31(14):1771-80. doi: 10.1038/onc.2011.362. Epub 2011 Aug 15.

50.

The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.

Modlin IM, Moss SF, Gustafsson BI, Lawrence B, Schimmack S, Kidd M.

Langenbecks Arch Surg. 2011 Dec;396(8):1145-56. doi: 10.1007/s00423-011-0794-7. Epub 2011 Apr 27. Review.

PMID:
21523447

Supplemental Content

Support Center